vs
Side-by-side financial comparison of Tonix Pharmaceuticals Holding Corp. (TNXP) and Xos, Inc. (XOS). Click either name above to swap in a different company.
Tonix Pharmaceuticals Holding Corp. is the larger business by last-quarter revenue ($5.4M vs $5.2M, roughly 1.0× Xos, Inc.). Xos, Inc. runs the higher net margin — -186.8% vs -870.3%, a 683.5% gap on every dollar of revenue. On growth, Tonix Pharmaceuticals Holding Corp. posted the faster year-over-year revenue change (108.8% vs -54.5%). Over the past eight quarters, Tonix Pharmaceuticals Holding Corp.'s revenue compounded faster (47.4% CAGR vs -35.7%).
Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project.
Xos, Inc. is an American manufacturer of commercial electric vehicles (EVs) and mobile EV chargers.
TNXP vs XOS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $5.4M | $5.2M |
| Net Profit | $-46.9M | $-9.8M |
| Gross Margin | 80.4% | -50.5% |
| Operating Margin | -895.8% | -186.6% |
| Net Margin | -870.3% | -186.8% |
| Revenue YoY | 108.8% | -54.5% |
| Net Profit YoY | -112.2% | 48.6% |
| EPS (diluted) | $-4.28 | $-0.76 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $5.4M | $5.2M | ||
| Q3 25 | $3.3M | $16.5M | ||
| Q2 25 | $2.0M | $18.4M | ||
| Q1 25 | $2.4M | $5.9M | ||
| Q4 24 | $2.6M | $11.5M | ||
| Q3 24 | $2.8M | $15.8M | ||
| Q2 24 | $2.2M | $15.5M | ||
| Q1 24 | $2.5M | $12.6M |
| Q4 25 | $-46.9M | $-9.8M | ||
| Q3 25 | $-32.0M | $2.1M | ||
| Q2 25 | $-28.3M | $-7.5M | ||
| Q1 25 | $-16.8M | $-10.2M | ||
| Q4 24 | $-22.1M | $-19.0M | ||
| Q3 24 | $-14.2M | $-10.5M | ||
| Q2 24 | $-78.8M | $-9.7M | ||
| Q1 24 | $-14.9M | $-11.0M |
| Q4 25 | 80.4% | -50.5% | ||
| Q3 25 | 58.4% | 15.3% | ||
| Q2 25 | -63.8% | 8.8% | ||
| Q1 25 | 61.2% | 20.6% | ||
| Q4 24 | 54.2% | -32.4% | ||
| Q3 24 | 44.9% | 18.1% | ||
| Q2 24 | -52.5% | 13.1% | ||
| Q1 24 | 33.1% | 22.1% |
| Q4 25 | -895.8% | -186.6% | ||
| Q3 25 | -1005.1% | -42.4% | ||
| Q2 25 | -1416.2% | -38.5% | ||
| Q1 25 | -660.9% | -157.7% | ||
| Q4 24 | -870.6% | -127.0% | ||
| Q3 24 | -551.2% | -61.4% | ||
| Q2 24 | -3501.6% | -73.2% | ||
| Q1 24 | -860.2% | -81.1% |
| Q4 25 | -870.3% | -186.8% | ||
| Q3 25 | -972.9% | 12.9% | ||
| Q2 25 | -1415.0% | -40.8% | ||
| Q1 25 | -692.8% | -173.3% | ||
| Q4 24 | -856.2% | -165.4% | ||
| Q3 24 | -503.6% | -66.6% | ||
| Q2 24 | -3567.8% | -62.2% | ||
| Q1 24 | -601.9% | -87.1% |
| Q4 25 | $-4.28 | $-0.76 | ||
| Q3 25 | $-3.59 | $0.22 | ||
| Q2 25 | $-3.86 | $-0.91 | ||
| Q1 25 | $-2.84 | $-1.26 | ||
| Q4 24 | $2302.65 | $-2.34 | ||
| Q3 24 | $-22.68 | $-1.32 | ||
| Q2 24 | $-1920.85 | $-1.23 | ||
| Q1 24 | $-535.72 | $-1.80 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $207.6M | $14.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $245.2M | $23.3M |
| Total Assets | $277.2M | $60.4M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $207.6M | $14.0M | ||
| Q3 25 | $190.1M | $14.1M | ||
| Q2 25 | $125.3M | $8.8M | ||
| Q1 25 | $131.7M | $4.8M | ||
| Q4 24 | $98.8M | $11.0M | ||
| Q3 24 | $28.2M | $8.4M | ||
| Q2 24 | $4.2M | $19.7M | ||
| Q1 24 | $7.0M | $46.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $8.7M | — | ||
| Q3 24 | $9.4M | — | ||
| Q2 24 | $10.1M | — | ||
| Q1 24 | $10.8M | — |
| Q4 25 | $245.2M | $23.3M | ||
| Q3 25 | $231.1M | $31.1M | ||
| Q2 25 | $168.0M | $18.3M | ||
| Q1 25 | $180.4M | $24.8M | ||
| Q4 24 | $139.6M | $33.6M | ||
| Q3 24 | $74.2M | $50.8M | ||
| Q2 24 | $42.1M | $59.2M | ||
| Q1 24 | $108.1M | $67.8M |
| Q4 25 | $277.2M | $60.4M | ||
| Q3 25 | $252.4M | $73.8M | ||
| Q2 25 | $187.4M | $80.3M | ||
| Q1 25 | $192.9M | $87.7M | ||
| Q4 24 | $162.9M | $98.3M | ||
| Q3 24 | $95.0M | $120.5M | ||
| Q2 24 | $70.3M | $123.4M | ||
| Q1 24 | $135.3M | $135.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.06× | — | ||
| Q3 24 | 0.13× | — | ||
| Q2 24 | 0.24× | — | ||
| Q1 24 | 0.10× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-39.6M | $2.4M |
| Free Cash FlowOCF − Capex | $-41.5M | — |
| FCF MarginFCF / Revenue | -770.4% | — |
| Capex IntensityCapex / Revenue | 34.8% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-103.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-39.6M | $2.4M | ||
| Q3 25 | $-28.8M | $3.1M | ||
| Q2 25 | $-14.8M | $4.6M | ||
| Q1 25 | $-16.6M | $-4.8M | ||
| Q4 24 | $-14.6M | $3.3M | ||
| Q3 24 | $-18.8M | $-11.5M | ||
| Q2 24 | $-9.9M | $-26.0M | ||
| Q1 24 | $-17.6M | $-14.6M |
| Q4 25 | $-41.5M | — | ||
| Q3 25 | $-29.7M | — | ||
| Q2 25 | $-15.4M | — | ||
| Q1 25 | $-16.6M | — | ||
| Q4 24 | $-14.6M | — | ||
| Q3 24 | $-18.8M | $-11.7M | ||
| Q2 24 | — | $-26.1M | ||
| Q1 24 | $-17.7M | $-14.6M |
| Q4 25 | -770.4% | — | ||
| Q3 25 | -904.1% | — | ||
| Q2 25 | -768.8% | — | ||
| Q1 25 | -682.8% | — | ||
| Q4 24 | -566.7% | — | ||
| Q3 24 | -666.5% | -73.9% | ||
| Q2 24 | — | -168.1% | ||
| Q1 24 | -712.4% | -115.7% |
| Q4 25 | 34.8% | 0.0% | ||
| Q3 25 | 29.2% | 0.0% | ||
| Q2 25 | 26.4% | 0.0% | ||
| Q1 25 | 0.2% | 0.0% | ||
| Q4 24 | 0.1% | 0.0% | ||
| Q3 24 | 0.3% | 0.9% | ||
| Q2 24 | 0.0% | 0.8% | ||
| Q1 24 | 4.4% | 0.2% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.45× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
TNXP
| Zembrace Symtouch | $3.1M | 58% |
| Other | $2.3M | 42% |
XOS
Segment breakdown not available.
